Cholesterol, lipid rafts, and disease

Journal of Clinical Investigation

Volumn 110, Issue 5, 2002, Pages 597-603

  Simons, K ^a   Ehehalt, R ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CAVEOLIN; CHOLESTEROL; GLYCOSYLPHOSPHATIDYLINOSITOL; LIPID; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE; PHOSPHOLIPID; PROTEIN KINASE P60; SONIC HEDGEHOG PROTEIN; SPHINGOLIPID;

ALZHEIMER DISEASE; CAVEOLA; CELL MEMBRANE; CHOLESTEROL TRANSPORT; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM; ENDOSOME; HUMAN; INTRACELLULAR TRANSPORT; LIPID BILAYER; LIPID MEMBRANE; LIPID RAFT; MOLECULAR SIZE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; RISK FACTOR; VIRUS INFECTION;

EID: 0036733578     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216390     Document Type: Review

References (56)

1. Lipid rafts and signal transduction
2. Insolubility of lipids in triton X-100: Physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts)
3. Functions of lipid rafts in biological membranes
4. Cholesterol modification of Hedgehog family proteins
5. Lipid domain structure of the plasma membrane revealed by patching of membrane components
6. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells
7. Lipid traffic in animal cells
8. Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles
9. Role of membrane organization and membrane domains in endocytic lipid trafficking
10. How cells handle cholesterol
11. Regulation and mechanisms of macrophage cholesterol efflux
12. Consequences of cellular cholesterol accumulation: Basic concepts and physiological implications
13. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells
14. Mapping the lipid distribution in the membranes of BHK cells (mini-review)
15. The role of lipid rafts in T cell antigen receptor (TCR) signaling
16. Membrane organization in immunoglobulin E receptor signaling
17. Fc(epsilon)RI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells
18. A perspective: Regulation of IgE receptor-mediated mast cell responses by a LAT-organized plasma membrane-localized signaling complex
19. Stimulated release of fluorescently labeled IgE fragments that efficiently accumulate in secretory granules after endocytosis in RBL-2H3 mast cells
20. Why cytoplasmic signaling proteins should be recruited to cell membranes
21. Membrane insertion: The strategies of toxins (review)
22. Plasma membrane microdomains act as concentration platforms to facilitate intoxication by aerolysin
23. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae
24. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
25. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities
26. Membrane microdomains and caveolae
27. Caveolin-deficient mice: Insights into caveolar function and human disease
28. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency
29. Endocytosis via caveolae
30. Distinction between signaling mechanisms in lipid rafts vs. caveolae
31. Floating the raft hypothesis: Lipid rafts play a role in immune cell activation
32. The therapeutic potential of modulating the ceramide/sphingomyelin pathway
33. Raft membrane domains: From a liquid-ordered membrane phase to a site of pathogen attack
34. Influenza viruses select ordered lipid domains during budding from the plasma membrane
35. Influenza virus assembly and lipid raft microdomains: A role for the cytoplasmic tails of the spike glycoproteins
36. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1
37. Lipid rafts and HIV-1: From vital entry to assembly of progeny virions
38. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection
39. Plasma membrane rafts play a critical role in HIV-1 assembly and release
40. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type I isolates into cell lines expressing CD4, CXCR4, and/or CCR5
41. Nef increases infectivity of HIV via lipid rafts
42. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
43. The Nef protein of HIV-1 associates with rafts and primes T cells for activation
44. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains
45. Alzheimer's disease: Genes, proteins, and therapy
46. Cholesterol and Alzheimer's disease: Is there a link?
47. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study
48. Statins and the risk of dementia
49. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
50. Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture
51. Acceleration of 'amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles
52. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads?
53. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes
54. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform
55. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection
56. Transfer of scrapie prion infectivity by cell contact in culture